Robert Avram
Montreal, Quebec, H1T1C8, Canada
NCT Number: NCT05317286
Left ventricular ejection fraction (LVEF) is one of the strongest predictors of mortality and morbidity in patients with acute coronary syndrome (ACS). Transthoracic echocardiography (TTE) remains the gold standard for LVEF measurement. Currently, LVEF can be estimated at the time of the coronary angiogram but requires a ventriculography. This latter is performed at the price of an increased amount of contrast media injected and puts the patients at risk for mechanical complications, ventricular arrhythmia or atrio-ventricular blocks. Artificial intelligence (AI) has previously been shown to be an accurate method for determining LVEF using different data sources. Fur the purpose of this study, we aim at validating prospectively an AI algorithm, called CathEF, for the prediction of real-time LVEF (AI-LVEF) compared to TTE-LVEF and ventriculography in patients undergoing coronary angiogram for ACS.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montreal, Quebec, H1T1C8, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: At 7 days or before discharge, if earlier.
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Either 7 days before or up to 7 days after the coronary angiogram
Time frame: Through study completion, an average of 1 year.
Montreal Heart Institute
Other
Prospective Validation of a Deep Learning Algorithm for Prediction of the Left Ventricular Ejection Fraction From Coronary Angiogram Videos in Patients With Acute Coronary Syndrome
Acronym: CathEF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03787810
Acute Coronary Syndrome, Cardiomyopathies
Gothenburg, Västra Götalandsregionen, Sweden
View Trial DetailsNCT05853042
Acute Coronary Syndrome, Acute Myocardial Infarction
Minneapolis, Minnesota, United States
View Trial DetailsNCT05992259
Acute Coronary Syndrome, Arrhythmias, Cardiac
Krasnodar, Russia
View Trial DetailsNCT06440278
Acute Coronary Syndrome, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial Details